Correlation Between Pfizer and ADMA Biologics
Can any of the company-specific risk be diversified away by investing in both Pfizer and ADMA Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ADMA Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and ADMA Biologics, you can compare the effects of market volatilities on Pfizer and ADMA Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ADMA Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ADMA Biologics.
Diversification Opportunities for Pfizer and ADMA Biologics
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pfizer and ADMA is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ADMA Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ADMA Biologics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ADMA Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ADMA Biologics has no effect on the direction of Pfizer i.e., Pfizer and ADMA Biologics go up and down completely randomly.
Pair Corralation between Pfizer and ADMA Biologics
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.48 times more return on investment than ADMA Biologics. However, Pfizer Inc is 2.09 times less risky than ADMA Biologics. It trades about 0.09 of its potential returns per unit of risk. ADMA Biologics is currently generating about -0.13 per unit of risk. If you would invest 2,482 in Pfizer Inc on December 4, 2024 and sell it today you would earn a total of 161.00 from holding Pfizer Inc or generate 6.49% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. ADMA Biologics
Performance |
Timeline |
Pfizer Inc |
ADMA Biologics |
Pfizer and ADMA Biologics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and ADMA Biologics
The main advantage of trading using opposite Pfizer and ADMA Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ADMA Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ADMA Biologics will offset losses from the drop in ADMA Biologics' long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |